Scientists find a blood test that predicts lung cancer years early
Researchers have identified a '14-protein signature' in blood plasma that can predict lung cancer years before clinical diagnosis. By utilizing data from the U.K. Biobank, the study suggests that this liquid biopsy method could enable proactive medical interventions.
Why it matters
Early detection of lung cancer significantly improves survival rates, potentially transforming the disease from a late-stage diagnosis to a manageable condition.
Lung cancer is one of the more common cancers affecting people worldwide. This is mainly thanks to smoking and, to a lesser extent, air pollution and occupational exposure. According to the latest World Health Organization estimates, there are about 2.5 million new cases and 1.8 million deaths every year. Prevention offers the ideal solution to this public health problem.
The article reports on scientific findings from a peer-reviewed journal without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in